These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33869220)

  • 21. A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
    Zhai WY; Duan FF; Chen S; Wang JY; Lin YB; Wang YZ; Rao BY; Zhao ZR; Long H
    Front Genet; 2021; 12():798131. PubMed ID: 35069695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
    Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
    BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma.
    Cao Y; Lu X; Li Y; Fu J; Li H; Li X; Chang Z; Liu S
    PeerJ; 2020; 8():e10320. PubMed ID: 33344071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate Cancer.
    Liu Z; Pan R; Li W; Li Y
    Front Oncol; 2021; 11():796795. PubMed ID: 35087757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
    Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
    Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
    Zhao H; Chen Y; Shen P; Gong L
    Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma.
    Zhu S; Lin F; Chen Z; Jiang X; Zhang J; Yang Q; Chen Y; Wang J
    Front Genet; 2020; 11():563882. PubMed ID: 33101383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 30. CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer.
    Sun X; Wang Z; Chen X; Shen K
    Front Cell Dev Biol; 2021; 9():646774. PubMed ID: 33816496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
    Hou C; Cai H; Zhu Y; Huang S; Song F; Hou J
    Front Oncol; 2020; 10():558596. PubMed ID: 33178587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 34. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma.
    He L; Chen J; Xu F; Li J; Li J
    Mol Ther Oncolytics; 2020 Dec; 19():265-277. PubMed ID: 33209981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
    Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
    Front Genet; 2022; 13():851373. PubMed ID: 35401707
    [No Abstract]   [Full Text] [Related]  

  • 40. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.